Login / Signup

Oral docetaxel plus encequidar - a phase 1 clinical trial.

David WangNoelyn HungTak HungKaren EdenWing-Kai ChanRudolf KwanAlbert QinCynthia ChangStephen DuffullPaul GlueChristopher Jackson
Published in: Cancer chemotherapy and pharmacology (2024)
U1111-1173-5473.
Keyphrases
  • clinical trial
  • phase ii
  • open label
  • double blind
  • study protocol
  • locally advanced
  • phase iii
  • randomized controlled trial
  • squamous cell carcinoma